Daily Stock List
AMR Corp. (AAMRQ)
Greenbackers, Orbit Stocks, StreetInsider, Blaque Capital Stocks, MarketWatch, and Penny Stock Rumble reported earlier on AMR Corp. (AAMRQ), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
American Airlines, Inc. and American Eagle Airlines, Inc. are subsidiaries of AMR Corp. American Airlines, American Eagle® and the AmericanConnection® carrier serve 260 airports in more than 50 countries and territories with, on average, greater than 3,500 daily flights. The combined network fleet numbers more than 900 aircraft. AMR common stock trades on the OTCQB marketplace. The Company has their corporate headquarters in Fort Worth, Texas.
AMR has several businesses and key facilities within their corporate structure. The Company is also a founding member of the global oneworld Alliance. All aspects of the airline's worldwide activities are overseen from AMR's Corporate Headquarters campus in Fort Worth. AMR's headquarters occupies a total of approximately 1.4 million square feet and is home to over 4,300 employees. The Headquarters is at the heart of the airline's global route network.
On Sept. 17, 2009, AMR announced plans to strengthen their network by reallocating capacity to hubs in Dallas/Fort Worth, Chicago, Miami and New York and enhance their fleet to better serve customers. These four cities, along with Los Angeles, serve as the cornerstones of AMR’s network.
American Airlines is a founding member of the global oneworld® Alliance. It brings together 11 of the world's biggest and best airlines and 20 affiliate carriers. This enables them to offer their customers more services and benefits than any airline can provide on their own. Together, their members and members-elect serve over 900 destinations with more than 9,000 daily flights to 150 countries and territories.
American Eagle is a regional airline affiliate. The American Eagle network is one of the largest regional airline systems in the world. It connects passengers to and from American flights at their hubs and other key cities. It operates over 260 aircraft with more than 1,500 flights daily, and serves more than 160 cities throughout the U.S., Canada, The Bahamas, Mexico and the Caribbean.
Today, American Airlines announced that The Something mAAgic Foundation® and American Airlines are partnering to provide children with life-threatening medical conditions and their families a seven-day retreat in Orlando, Florida. Today, 39 courageous children will participate in the Something mAAgic Foundation's 17th annual mAAgic(SM) flight. This year's mAAgic flight will deliver these deserving families to Kissimmee, Florida. They will stay at the 70-acre Give Kids The World Village®, conveniently located near popular Orlando attractions.
AMR Corp. (AAMRQ), closed Friday’s trading session at $0.43, up 16.76%, on 4,675,274 volume with 670 trades. The average volume for the last 60 days is 1,244,002 and the stock's 52-week low/high is $0.24/$0.832.
Eco Oro Minerals Corp. (EOM.TO)
Today we choose to report on Eco Oro Minerals Corp. (EOM.TO), here at the QualityStocks Daily Newsletter.
Eco Oro Minerals Corp. is a precious metals exploration and development company that lists on the Toronto Stock Exchange. The Company has a portfolio of projects in Colombia. Eco Oro has been focusing on their wholly-owned, multi-million ounce Angostura gold-silver deposit, located in northeastern Colombia, for more than 15 years during which the Company has invested over $200 million in the project's development and in that of the surrounding communities. Eco Oro Minerals is headquartered in Vancouver, British Columbia. Their exploration and administrative offices in Colombia are located in the cities of Bucaramanga and Bogotá.
Eco Oro’s dedication is to further advancing the Angostura Underground Project in a socially and environmentally responsible manner. The Angostura Project is located approximately 67 kilometers northeast of Bucaramanga. The Angostura Project consists of the main Angostura deposit and four key satellite prospects. These are Móngora, La Plata, Armenia and Violetal. Including the Angostura Project, Eco Oro Minerals has concessions, exploration licenses and exploitation permit areas covering an area of approximately 30,000 hectares in the Departments of Santander and Norte de Santander, Colombia.
An updated preliminary economic assessment (PEA) supported by a National Instrument 43-101 compliant technical report dated March 23, 2012 indicates that Angostura has the potential to produce 222,000 to 303,000 gold equivalent ounces for 10 years. The Company is presently completing a prefeasibility study on Angostura to determine the optimal project configuration and production rate.
An initial mineral resource estimate for Móngora, supported by a National Instrument 43-101 compliant technical report dated April 18, 2012, indicates an inferred mineral resource estimate of 3.1 million tonnes grading 2.86 grams per tonne gold and 4.62 grams per tonne of silver for a contained 282,867 ounces of gold and 456,938 ounces of silver at a cutoff grade of 1.5 grams per tonne gold. The close proximity of Móngora to Angostura opens up the possibility of developing Móngora as an early source of production in the development of the Angostura Project.
La Plata is within the Angostura Project area. It consists of 78 hectares of mineral rights contiguous on the majority of its borders with existing Eco Oro holdings.
Yesterday, Eco Oro announced an update on recent corporate developments. Due to recent prejudicial rulings relating to Eco Oro's principal mining title, concession 3452, and the ongoing delay in defining the boundaries of the proposed Regional Park and Páramo of Santurbán, the Company is implementing certain cost reduction initiatives, which include staff reductions and the suspension of further exploration activities, effective immediately.
These measures are being implemented with a view to Eco Oro's treasury while the Company makes a concerted effort and applies suitable resources to work with the Colombian authorities to favorably resolve these issues. Eco Oro expects to complete the prefeasibility study for the Angostura Underground Project by year-end.
Eco Oro Minerals Corp. (EOM.TO), closed Friday’s trading session at $0.83, down 2.35%, on 4,932,288 volume. The stock's 52-week low/high is $0.73/$3.22.
Greenlite Ventures, Inc. (GLTV)
Winning Penny Stock Picks, WePickPennyStocks, Super Nova Stock Picks, Super Hot Penny Stocks, PennyStockPickAlert, PennyStockMoneyTrain, and Liquid Tycoon reported yesterday on Greenlite Ventures, Inc. (GLTV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTC Bulletin Board (OTCQB), Greenlite Ventures, Inc. is a carbon offsets marketing company. They market carbon offsets by way of their website to voluntary markets where no verification is required. Greenlite has the exclusive agreement to sell offsets generated by United Nature. United Nature owns and manages sustainable teak plantations and invests in buying rainforest for reforestation. United Nature projects are located in Darien Province, Panama. Incorporated on December 21, 2000 under the laws of the State of Nevada, Greenlite Ventures is based in Blaine, Washington.
Currently, United Nature has 1,700 hectares (approximately 4,200 acres) under ownership or management. Each hectare sequesters approximately ten tons of atmospheric carbon annually. United Nature plants in jungle areas that have been damaged because of illegal or unethical tree harvesting practices such as clear-cutting.
Greenlite's longer term plan is to market and sell verified Deforestation and Degradation (REDD) carbon offsets from global restoration projects. The Company’s focus is on reforestation, ideally with producers, similar to United Nature, who provide work opportunities and benefits to the indigenous people. Additionally, Greenlite's longer term plans include looking to join carbon exchanges and marketing other forms of verified carbon credits.
Carbon Offsets are generated by projects that reduce the amount of carbon in the atmosphere helping to reduce global warming. Greenlite Ventures reforestation project helps reduce global warming and allows the indigenous people of Panama to become self-sufficient through education, job creation and promoting sustainability.
Earlier this month, Greenlite Ventures announced that they entered into a revised Letter Of Intent (LOI) for the acquisition of 66.67 percent of Advantag AG. Advantag is a German-based company engaged in the business of marketing and trading carbon credits. They are a member of a number of European carbon exchanges, including the Carbon Trade Exchange London/Melbourne (a leading exchange for sale of voluntary credits), the Green Market Exchange of the Bavarian Exchange in Munich, Climex in the Netherlands, and the KBB Bratislava. The acquisition of control of Advantag will assist Greenlite Ventures in marketing of the carbon offsets generated by the United Nature projects and will allow Greenlite to achieve their longer term plan to join carbon exchanges and market other forms of carbon credits.
Greenlite Ventures, Inc. (GLTV), closed Friday’s trading at $0.0072, down 14.29%, on 395,600 volume with 21 trade. The average volume for the last 60 days is 474,039 and the stock's 52-week low/high is $0.0025/$0.2125.
ICTS International N.V. (ICTSF)
Today we are highlighting ICTS International N.V. (ICTSF), here at the QualityStocks Daily Newsletter.
ICTS International N.V., together with their subsidiaries, provides airport security and other aviation related services. The Company does this through service contracts with airlines and airports primarily in the United States, the Netherlands, and Japan. ICTS has an emphasis on transportation security in general, and railroad and mass transport security in particular. The Company’s shares trade on the OTCQB. Founded in 1982 by a select group of security experts, ICTS has their headquarters in Amstelveen, The Netherlands.
I-SEC – International Security B.V., a fully-owned subsidiary of ICTS International, was established in 2005 as the aviation security arm of the ICTS International N.V. Group. Since the subsidiary established, new I-SEC Activities and Operations have been established in a number of European countries to efficiently supply aviation security services locally. Furthermore, highly specialized security service contracts with major U.S. carriers across Europe have been awarded to I-SEC. Currently; I-SEC operates in The Netherlands, France, Germany, the United Kingdom, Spain, Hungary, Romania and Russia. This subsidiary is continuing to expand to other countries in Europe.
AU10TIX Ltd. is a full subsidiary of ICTS International. They serve as the technology arm of ICTS. AU10TIX emerged as an independent company, implementing the extensive expertise and experience accumulated over the years with ICTS' worldwide activities. AU10TIX is a leading provider of document acquisition, authentication and comprehension products. Their products significantly reduce identity fraud, eliminate human errors, decrease data redundancies and gaps, and reduce costumer handling costs. These do so while streamlining sales and service operations.
In January 1999, ICTS acquired Huntleigh Corp. Headquartered in St. Louis, Missouri; Huntleigh operates at 31 U.S. airports, including most of the international aviation gateways in the U.S. The services that ICTS/Huntleigh USA provide include security agents, charter flights security screening, skycap and wheelchair services, baggage handling, aircraft cleaning, queue monitors, janitorial services, guards, ramp agents, passenger service agents, baggage service agents, crew transport, baggage x-ray, aircraft search, vendor security screening, and more.
ICTS International N.V. (ICTSF), closed Friday’s trading at $1.50, down 50.00%, on 966 volume with 3 trades. The average volume for the last 60 days is 1,004 and the stock's 52-week low/high is $0.11/$1.90.
Klondike Gold Corp. (KG.V)
Today we are highlighting Klondike Gold Corp. (KG.V), here at the QualityStocks Daily Newsletter.
Klondike Gold Corp. is an exploration company focusing on the development of their Yukon and British Columbia gold properties. The Company also holds a large portfolio of base metal projects in southeastern British Columbia. Klondike Gold has offices in Vancouver, British Columbia, and Dawson City, Yukon. The Company’s shares trade on the TSX Venture Exchange.
Klondike Gold controls key hard rock claims that made the Klondike famous. The gold field is reported to have produced more than 20 million ounces of alluvial gold. The Company’s mission is to find the hard rock source for one of the largest unexplained gold anomalies in the world.
The focus of the Company is the Lone Star Project; a new campaign is underway to assess the significant volumes of exploration data available. The most important source of placer gold is Eldorado and Bonanza Creeks and Klondike Gold owns and controls the claims covering these areas. Exploration this calendar year on the Lone Star is focusing on low-grade near surface bulk tonnage targets and also high-grade vein mineralization.
Klondike Gold’s intended activities on the Lone Star include a systematic property wide soil geochemistry program with an infill contingency of additional samples for high priority areas; property wide geological mapping and rock sampling, and trenching and pitting with channel samples where appropriate.
Today, Klondike Gold announced encouraging results for the Violet vein trend, 310 Zone, and recently discovered Boy soil anomaly. These results in conjunction with Boulder Lode open cut results will direct 2013 exploration and drilling. The 2012 exploration highlights include Violet grab samples of 41.25 g/t Au with 524 g/t Ag and 47.4 g/t Au with 894 g/t Ag (fire assay); Violet vein trend advancement towards and beyond the 310 zone 4 km to the northwest, and the New Boy zone 400 x 900 meter open ended soil anomaly.
Klondike Gold's 2012 Violet exploration program concentrated on prospecting, rock sampling, and soil sample lines to better define the mineralization of the Violet trend associated with the historic Violet Mine. The newly discovered Boy zone at the headwaters of Little Blanche creek was soil sampled by contractor Ground Truth Exploration, Inc. Boy results show a strong north-south trending anomaly with a width of approximately 400 meters and a length of 900 meters that is open to extension at either end.
The 2012 summer exploration season was successful in advancing confidence in gold mineralization of the Lone Star property to a level where solid drill targets are ready for the 2013 season. President and CEO Erich Rauguth commented, "What is important to understand is that across the 135 square kilometer area of the Lone Star Property there is genuine potential. There is already in excess of ten million ounces of placer gold production from the Klondike Gold Fields much of it derived from the Lone Star property's hard rock sources."
Klondike Gold Corp. (KG.V), closed Friday’s trading session at $0.09, up 50.00%, on 3,444,366 volume. The average stock's 52-week low/high is $0.05/$0.24.
Orgenesis, Inc. (ORGS)
OTCPicks, IRGnews Alert, and pastwellness.com reported on Orgenesis, Inc. (ORGS), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTCBB, Orgenesis, Inc. is a development stage company with a novel therapeutic approach in the treatment of diabetes. This is through correcting malfunctioning organs with new functional tissues created from the patient's own existing organs. The Company employs a molecular and cellular approach directed at converting liver cells into functional insulin-producing cells as a treatment for diabetes. This new therapeutic approach goes by the name Autologous Insulin Producing (AIP) cell transplantation. Orgenesis is based in White Plains, New York.
The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk of transplant rejection. Orgenesis has manifested promising results in in-vitro and in-vivo studies using human liver tissues. The Company has designed an efficient and clear work-plan to initiate clinical testing allowing them to launch Phase I clinical trials following FDA guidelines followed by the launch of Phase II clinical trials.
The basis of their technology is on Intellectual Property (IP) licensed from Israel's acclaimed Sheba Medical Center. The basis of this portfolio is on the innovative work and two decades of research by the world-renowned researcher, Prof. Sarah Ferber. Prof. Ferber is the head of the endocrine research unit at Sheba Medical Center.
Orgenesis' technology has undergone development following extensive animal safety testing and the research has matured to the stage of clinical development. More than 50 centers around the world are highly qualified for Pancreatic Islet transplantation. It is the Company’s intention to work closely with such leading centers to enable Autologous Insulin Producing (AIP) cell transplantation as a therapeutic approach in the treatment of diabetes at those centers.
Earlier, Orgenesis was featured in two online publications during the week of June 11, 2012. Sarah Ferber, Ph.D., Chief Science Officer of Orgenesis contributed a guest column to the June 11 edition of Clinical Leader. Titled “Using a Diabetes Patient’s Own Liver Cells as a Novel Source of Insulin,” the column outlines the autologous cell replacement therapy for diabetes patients currently under development at Orgenesis. Dr. Ferber also contributed a bylined article to the June 15 edition of BioMedReports with the same title and focus.
Orgenesis, Inc. (ORGS), closed Friday’s session at $0.87, up 1.75%, on 37,900 volume with 22 trades. The average volume for the last 60 days is 5,757 and the stock's 52-week low/high is $0.31/$1.66.
San Gold Corp. (SGRCF)
Vantage Wire and Streetwise Reports reported earlier on San Gold Corp. (SGRCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
San Gold Corp. is an established gold producer, explorer, and developer. The Company owns and operates the Hinge, 007, and Rice Lake mines near Bissett, Manitoba. San Gold lists on the Toronto Stock Exchange under the symbol "SGR" and on the OTCQX International under the symbol "SGRCF". The Company has their corporate headquarters in Winnipeg, Manitoba.
The Rice Lake Mine was originally built in 1934; it remains a core part of operations. It reaches 5,500 feet below the surface along two shafts. The Rice Lake Mine contains reserves of 33,435 ounces (196,531 tons at 5.83 grams per ton), measured plus indicated resources [inclusive of reserves] of 198,100 ounces (793,095 tons at 8.56 grams per ton), and inferred resources total 471,091 ounces (1,690,997 tons at 9.55 grams per ton). The zone is open at depth below the lower mine level. Mining operations in the Rice Lake Mine are currently focusing on the 98 Vein in the Rice Lake East portion of the mine, between 26 Level and 28 Level, located approximately 4,100 feet below the surface.
The Hinge district was discovered in 2007. The Hinge district contains reserves of 32,594 (135,466 tons at 5.14 grams per ton), measured plus indicated resources [inclusive of reserves] of 32,594 ounces (165,007 at 6.77 grams per ton), and inferred resources of 604,604 ounces (3,362,500 tons at 6.16 grams per ton). The main mining method used in the Hinge district is mechanical cut and fill. The Hinge ramp allows ore to be driven to surface by truck.
The 007 deposit is accessed by a 730 meter drift leading from the Hinge portal approximately 240 meters below surface. The 007 deposit currently accounts for approximately half of all ounces produced at the Rice Lake Project. The 007 Zone contains reserves of 126,510 ounces (642,188 tons at 6.75 grams per ton), measured plus indicated resources [inclusive of reserves] of 134,654 ounces (521,990 tons at 8.84 grams per ton), and inferred resources of 1,483,893 ounces (5,707,280 tons at 8.91 grams per ton).
This week, San Gold announced the appointment of Mr. Michael Michaud as Vice President, Exploration. Mr. Michaud is a professional geologist with more than 25 years of experience in mineral deposit exploration and mining. He recently held the position of Vice President of Exploration for St. Andrew Goldfields Ltd.
San Gold Corp. (SGRCF), closed Friday’s session at $1.13, up 6.60%, on 184,057 volume with 139 trades. The average volume for the last 60 days is 58,083 and the stock's 52-week low/high is $0.71/$2.84.
WidePoint Corp. (WYY)
Hayden IR reported yesterday on WidePoint Corp. (WYY), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
WidePoint Corp. is a leading provider of wireless mobility management and cyber security solutions. They provide their solutions using their advanced information technology products and services. The Company has grown through the merger of highly specialized regional IT consulting companies, most of who have been in business for decades. WidePoint has their headquarters in Oakbrook Terrace, Illinois. The Company lists on the NYSE market.
The Company enables organizations to deploy fully compliant IT services in accordance with government-mandated regulations and advanced system requirements. WidePoint has a number of wholly owned subsidiaries holding major government and commercial contracts. These include Operational Research Consultants, Inc., iSYS, LLC, Protexx, Advanced Response Concepts Corp., WidePoint Solutions/AGS and WidePoint IL.
For Wireless Telecommunications Expense Management, WidePoint applies on-staff expertise and proven solutions to manage wireless expenses for complex communication networks of cellular phones, Blackberries, PDAs, air cards, pagers and other devices.
Concerning Forensic Informatics, they provide Forensic Laboratory information technology needs to federal, state, and local law enforcement agencies throughout the United States. Pertaining to Identity Management, their information assurance services and systems are critical to maintaining the nation's security and leadership in technology. Their services range from Certification and Accreditation to System Architecture and Customizable Information Assurance plans and processes.
Additionally, the Company provides consulting services in the areas of Strategic Planning, Independent Verification and Validation, Help Desk Support, Training and Curriculum Development, Business Process Re-engineering, Security Architectural Analysis, Disaster Planning and Recovery, and Graphics Support. They offer architecture and planning services, software implementation services, and IT outsourcing.
Yesterday, WidePoint announced that Mr. Jim McCubbin, Executive Vice President and Chief Financial Officer of the Company, will present at Craig Hallum Capital Group's 2012 Alpha Select Conference in New York at 10:00 am Eastern Time on Thursday, September 27, 2012. The one-day conference will take place at Sentry Centers, 730 3rd Avenue in New York. WidePoint will present on the 17th Floor in the Nolita Room at 10:00 am Eastern Time. WidePoint will be available for one-on-one meetings on September 27.
WidePoint Corp. (WYY), closed Friday’s session at $0.43, up 5.26%, on 18,182 volume with 44 trades. The average volume for the last 60 days is 37,421 and the stock's 52-week low/high is $0.37/$0.97.
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $1.4670, up 8.67%, on 87,930 volume with 54 trades. The stock’s average daily volume over the past 60 days is 14,647, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech, Inc. Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)
Dr. Ronald Herberman Joins TNI BioTech Inc. as Senior Vice President of Research and Development and Chief Medical Officer
TNI BioTech, Inc. Acquires Portfolio of Exclusive Licenses to the Portfolio of Patents of Dr. Bernard Bihari
Duma Energy Corp. (DUMA)
The QualityStocks Daily Newsletter would like to spotlight Duma Energy Corp. (DUMA). Today, Duma Energy Corp. closed trading at $2.00, up 1.52%, on 2,245 volume with 4 trades. The stock’s average daily volume over the past 60 days is 8,052, and its 52-week low/high is $1.10/$4.00.
Duma Energy Corp. (DUMA) is an aggressive growth company actively producing oil and gas in the domestic United States, both on and offshore. Leveraging its technical expertise, promising portfolio, and strong financial condition, the company plans to utilize domestic revenues and cash flow to fund its rapid growth through acquisition, while participating in transformational projects with the potential of providing exponential returns for shareholders.
The company's primary goal for fiscal year 2012 and beyond is to drive earnings growth. The company also aims to pursue listing on major exchange(s) to provide better visibility and liquidity to shareholders and financial partners. Already producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana, Duma projects domestic production to exceed 1,000 barrels of oil equivalent per day (boepd) by the end of 2012; with 2,500 boepd projected by the end of 2013.
Duma was founded in 2005 and began trading on the OTCBB in 2009 via registration. In 2006, the company began producing from its first properties in Texas and soon after added production in Louisiana. In 2009, its new CEO Jeremy G. Driver came on board. Within one year, Mr. Driver had identified and negotiated an acquisition that would fundamentally reshape the company. This acquisition was made possible by the large direct cash investment by Mr. Driver and his family, as well as other investors.
The company uses only industry standard and time-tested technologies, and avoids unproven "resource plays" and other opportunities that are heavily dependent upon high commodity prices. Not bound by any geographical location or operational strategy, Duma's management team is focused on developing its existing portfolio while pursuing additional opportunities that provide rapid growth, leveraging growing revenue, cash flow, and reserves to accelerate its growth strategy. Disclaimer
Duma Energy Corp. Company Blog
Duma Energy Corp. News:
DUMA - Duma Energy Corp, Zacks Initiating Coverage
Duma Energy Corp. Partners with Hydrocarb to Explore for World Class Reserves in Africa Oil Concession
Duma Energy Receives Approval From Government of Namibia for Exploration License Issued for 5.3 Million-Acre Concession
Teletouch Communications, Inc. (TLLE)
The QualityStocks Daily Newsletter would like to spotlight Teletouch Communications, Inc. (TLLE). Today, Teletouch Communications, Inc. closed trading at $0.545, up 1.30%, on 22,700 volume with 11 trades. The stock’s average daily volume over the past 60 days is 25,220, and its 52-week low/high is $0.253/$0.89.
Teletouch Communications, Inc. (TLLE) offers a comprehensive suite of wireless telecommunications solutions, including cellular, GPS-telemetry, and wireless messaging. Founded in 1964, the company provides its products and services to consumers, businesses, and government agencies, operating a chain of 11 retail and authorized agent stores, in conjunction with its direct sales force, call center operations, and various retail eCommerce websites.
Through its wholly owned subsidiary, Progressive Concepts, Teletouch operates a national distribution business, PCI Wholesale, primarily serving Tier-1 (AT&T, T-Mobile, Verizon, Sprint) cellular carrier agents, Tier-2, Tier-3, and rural carriers, as well as auto dealers and smaller consumer electronics retailers. The subsidiary's international sales coverage includes Canada, Mexico, Brazil, Singapore, and China.
The company is currently focusing on growing its core wholesale distribution business. The business plan being executed includes selling non-core corporate assets and reviewing potential acquisition opportunities. Operators and retailers of all sizes are seeking new sources of revenue at lower costs, creating a large opportunity to provide great products and value-added distribution capabilities at competitive prices.
Teletouch's management team has extensive experience in financing, acquiring, and operating retail, wireless and other related companies. Robert McMurrey, Chairman and CEO, guided Teletouch's original external expansion with the completion of over 15 acquisitions to date. Today, the company supports over 60,000 wireless customers, leveraging its long-standing relationships and global presence to drive future earnings growth. Disclaimer
Teletouch Communications, Inc. Blog
Teletouch Communications, Inc. News:
Teletouch Announces Distribution Agreement with Unimax Communications for Sales of UMX Branded Cellular Handsets in North America
Teletouch Reports Fiscal Year 2012 Results
Teletouch 2012 Fiscal Year Ending May 31st Report Scheduled for August 29, 2012
Skinny Nutritional Corp. (SKNY)
The QualityStocks Daily Newsletter would like to spotlight Skinny Nutritional Corp. (SKNY). Today, Skinny Nutritional Corp. closed trading at $0.0043, on 1,199,200 volume with 14 trades. The stock’s average daily volume over the past 60 days is 1,690,274, and its 52-week low/high is $0.004/$0.042.
Skinny Nutritional Corp. (SKNY) has established their Skinny Water® brand as a clear alternative to other products in the enhanced water space, with the only true zero calorie, sugar, carb, sodium, and preservative-containing beverage available. Skinny Water's proprietary formulation of essential antioxidant agents, electrolytes, and the critical vitamins our bodies need in order to achieve optimal function, uses 100% natural flavors, no preservatives, no artificial colors, and only the best purified water.
The company has constructed a network of approximately 50 domestic distributors (with three more internationally), placing product on shelves approximately 15k stores across the United States. Derived from the natural flavors contained in fruits, Skinny Water represents a fortified, extremely low-impact, great-tasting array of beverages that provide a concentrated punch of the nutrients essential for a healthier lifestyle.
The company's strong emphasis on health, fitness, and community has served marketing initiatives very well. The new age beverage segment has seen increasing momentum in recent years, with just about every beverage company getting into the game, but none of them has the kind of no-nonsense product composition behind Skinny Water, something that appeals directly to the majority of the core consumer market.
Skinny Nutritional continues to build value around the Skinny Water brand, and today has numerous trademarks in the healthy beverage and snack food categories. As consumers migrate away from sugar based beverages and empty calories, Skinny Water is ideally positioned to benefit from positive market trends as management focuses on delivering exceptional value to shareholders. Disclaimer
Skinny Nutritional Corp. Blog
Skinny Nutritional Corp. News:
Skinny Nutritional Corp. to Change the Way You Think About Your Water With the Introduction of Skinny Water pH+
A&P's 275 Stores Continue Skinny Water's Mid-Atlantic Penetration
Skinny Nutritional Corp. Enters Into $15M Financing, Positions Company to Grow Skinny Brand Portfolio Nationally
September’s issue of BevNET Magazine, an important trade magazine for the beverage industry, highlighted Skinny Nutritional’s introduction of Skinny Water pH+, a high-alkaline and electrolyte-enhanced water. The water is specially formulated with minerals and serves as a new complement to Skinny’s many flavored health waters. Skinny Water pH+ is clear with ingredients designed to boost electrolytes for replenishment and added energy. The product also features educational materials at point-of-sale, and a tagline of “Body in Balance.”
Skinny Water pH+ is based upon the growing market for nutritional products that contribute to an improved acid-alkaline balance in the body, avoiding acid imbalance which is seen by many as contributing to low energy and more serious disorders. Although home water ionizing systems are available, the up-front expense is discouraging to most people. Skinny Water pH+ offers a simple and affordable way for consumers to get what they want.
Skinny Water pH+ is now distributed nationally, part of the Skinny brand’s growing distribution network. Skinny products can now be found across the country, at 15,000 retail locations, including major retailers such as Target and CVS. The brand is known for its unique line of exclusive 100% naturally flavored waters containing zero-sugar, zero-carbs, zero calories, and zero sodium, together with customized blends of nutrients targeting consumers interested in both health and taste.
BevNET Magazine is written for wholesalers, independent distributors, suppliers, supermarkets, and convenience stores. It’s designed to help increase retail beverage sales and covers all types of beverages, from coffee and tea, to wine and alcoholic spirits. BevNET is the leading industry publication for analysis of trends, innovation, marketing, and product development. The magazine is published 8 times per year. The BevNET website has the highest traffic and most content of any Web site dedicated to the non-alcoholic beverage industry and has been online since 1996.
For additional information, visit the company’s websites at www.SkinnyWater.com
Santa Fe Gold, the domestic precious/industrial minerals development firm with its sights set on becoming a major player in precious metals via the company’s Ortiz gold and Summit silver-gold projects, reported today that the company has successfully engaged London-based fund management and emerging market-class advisory services firm, Collabrium Capital, to provide comprehensive corporate finance advisory help in support of growing the business.
With a considerable presence already established through a global network of affiliated financial services, industry, and government partners, Collabrium is an exceptionally well positioned finance advisory firm, with far-reaching operational striking distance. With a century of experience developing/managing highly profitable financial institutions over in the UK held by the firm’s three principals, Collabrium is precisely the kind of strategic partner that SFEG needs to provide equity and fixed income over watch as the company continues to advance development of its properties.
The July 10 report from earlier this year that showed strong preliminary FY12 results for SFEG, characterized by a jump in sales of over 80% that was attributed to record production at the company’s Summit silver-gold mine in southwest New Mexico, is a perfect example of the kind of activity this strategic partnership will support. SFEG anticipates that revenues will continue to increase at a good clip over the next few quarters as the Summit mine proceeds into higher-grade ore bodies and with successful completion of the ramp-up to the 10k tons/month target rate, the flagship Summit silver-gold mine, as well as the roughly 66 square mile Ortiz Mine Grant in Santa Fe County, New Mexico, provide ample targets for Collabrium’s financial and market support capabilities.
CEO of SFEG, Pierce Carson, called the strategic partnership with Collabrium key to advancing the company’s growing portfolio of precious/base mineral properties, which also includes the 1,385-acre Black Canyon mica deposit north of Phoenix, Arizona, and the Planet Micaceous Iron Oxide project located on some 523 acres in western AZ. Carson underscored the financial strength of Collabrium, as well as the extremely deep sea of financial experience accessible via the firm’s managers, partners, and affiliates, assuring shareholders and investors alike that this move by SFEG would pan out nicely with increasing focus paid to the Summit project in particular. The Summit mining and processing operation includes the underground mine and Banner mill site (crushing/screening plant, ball mill, and the 400 ton/day flotation plant) where metallurgical processing occurs, consisting of roughly 857 acres (117 acres of patented mining claims, the rest unpatented) and the mill site-related 1,500 acre property (wholly owned and leased patented and unpatented mining claims).
CEO of Collabrium Capital, Stephen Couttie, echoing the sentiments expressed by Carson about how great an opportunity this move is for both Collabrium and SFEG, explained that the firm can provide a substantial contribution to the evolution of Santa Fe as a company, offering even as-yet-unanticipated downstream benefits that will be realized through introducing the company to markets where it (as yet) has little or no exposure. Couttie stressed the broad assistance the firm is capable of delivering to overall SFEG business development and said that his firm couldn’t wait to get started supercharging shareholder ROI endpoints for Santa Fe.
To get a closer look at the extensive mineral operations currently engaged by Santa Fe Gold Corp., please visit the company’s website located at: www.SantaFeGoldCorp.com
Dyax and Kadmon Corporation LLC yesterday announced they have entered into a strategic licensing agreement granting Kadmon an exclusive worldwide license for developing and commercializing the fully human monoclonal antibody DX-2400, which is a potent and selective antibody inhibitor of matrix metalloproteinase 14 (MMP-14). A key enzyme in a molecular pathway, MMP-14 is thought to play a role in tumor blood vessel formation (angiogenesis), as well as in affecting tumor growth and cell migration. According to the terms of the agreement, Dyax will be given an upfront payment and is eligible for significant development and commercial milestone payments, as well as tiered royalties on commercial sales up to a double-digit rate. Kadmon will be responsible, as an exclusive licensee, for further developing and commercializing DX-2400, which is presently in application-enabling studies for an investigational new drug (IND) application.
The strategic agreement further validates Dyax’s capabilities to successfully discover novel antibody drug candidates, utilizing the company’s proprietary phage display technology and moving the resulting drug candidates into development. The agreement expands Kadmon’s extensive history with Dyax and with the company’s antibody technology platform. Kadmon, which has a proven track record of developing and commercializing key new oncology products, believes MMP-14 is an important component in overcoming the growth, proliferation, and resistance mechanisms of cancer. MMP-14’s role in tumors and ocular disease neovascularization, in particular, presents a distinctive target opportunity that may complement other antiangiogenic therapies currently on the market and in development.
Targeting MMP-14 offers therapeutic potential in multiple oncology indications where high levels of active MMP-14 have been confirmed in human tumor tissue sample analysis. Dyax has previously demonstrated, in published work, that DX-2400 mediated inhibition of primary tumor growth, metastasis, and angiogenesis in preclinical models of breast, melanoma, and prostate cancer.
Dyax discovered DX-2400 using its “gold-standard” phage display technology, in which the company applied its considerable selection and screening expertise to selectively block catalytic activity of a single protease within a larger and closely related family of enzymes. This antibody is an additional example of the superior functional selectivity that is available to validate novel biologic targets using Dyax’s phage display libraries.
A fully integrated biopharmaceutical company, Dyax is engaged in the development and commercialization of novel biotherapeutics for unmet medical needs. Ecallantide, the company’s lead product, has received approval in the U.S. under the brand name KALBITOR for treating acute attacks of hereditary angioedema (HAE) in patients age 16 and older. The company is independently commercializing KALBITOR in the U.S. and is establishing strategic collaborations to develop and commercialize ecallantide for treating HAE in key regions throughout the world. Dyax currently has collaboration agreements for regions including Europe, Japan, Russia, the Middle East, Australia, and New Zealand. The company is additionally exploring other potential indications for ecallantide, either independently or collaboratively.
Ecallantide and other compounds in the Dyax pipeline were identified using the company’s patented phage display technology. The company broadly leverages this technology through the Licensing and Funded Research Program (LFRP). LFRP agreements collectively generate substantial revenue for Dyax in the form of license fees, milestone payments, and/or royalties.
For more information, visit the company’s Web site at www.dyax.com
Today, Dynatronics announced the introduction of its new line of Dynatron SolarisPlus products, which has been the result of a research and development initiative spanning three years. Four separate units make up the SolarisPlus product line: the SolarisPlus 709, 708, 706, and 705. These pioneering devices can provide seven waveforms of electrotherapy, as well as delivering Dynatronics’ patented three frequency ultrasound therapy and light therapy through a newly designed Tri-wave light probe and two light pads.
The company believes the Dynatron SolarisPlus units, its flagship products, are the most advanced devices of their kind on the market, representing the most powerful and versatile units available for the company’s practitioners and their patients.
The new, cutting-edge Tri-wave technology is comprised of red, infrared, and blue-wavelength light, delivered by means of two proprietary light pads for treating larger areas of the body or a light probe for treating smaller areas. The Tri-wave pads and light probes are substantially more powerful than their predecessors, offering a greater degree of flexibility in patient treatments. The Tri-wave devices have the capability of delivering seven different combinations of light therapy wavelengths, which enables practitioners to select the optimal treatment for each patient.
The SolarisPlus units can be mounted on a customized cart for easy transportation between clinic treatment stations. The new cart will be available in October.
The new SolarisPlus product line represents Dynatronics’ most comprehensive redesign project to date, updating the Solaris line that was originally introduced in 2003. The company anticipates the new products will stimulate higher sales of capital equipment.
Dynatronics is a manufacturer, marketer, and distributor of advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables, and rehabilitation equipment for the markets of physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology, and other related medical, cosmetic, and aesthetic fields.
For more information, visit the company’s Web site at www.dynatronics.com
Today's Top 3
Wall Street Resources
The QualityStocks Public Company Sponsor News